Financial Statements for Regeneron Pharmaceuticals Inc

Search Images Maps Play YouTube News Gmail Drive More »

Help | Sign in

Recent Quotes (30 days)

You have no recent quotes

chg | %

Regeneron Pharmaceuticals Inc financials

Watch this stock

Income Statement

Balance Sheet

Cash Flow

View: Quarterly Data | Annual Data

Hide charts

In Millions of USD (except for per share items)	3 months ending 2013-03-31	3 months ending 2012-12-31	3 months ending 2012-09-30	3 months ending 2012-06-30	3 months ending 2012-03-31
Revenue	439.66	414.60	427.69	304.40	231.79
Other Revenue, Total	-	-	-	-	-
Total Revenue	439.66	414.60	427.69	304.40	231.79
Cost of Revenue, Total	29.05	30.17	20.14	21.84	12.30
Gross Profit	410.61	384.43	407.54	282.56	219.49
Selling/General/Admin. Expenses, Total	77.26	57.74	46.88	47.70	58.43
Research & Development	180.30	181.02	158.29	147.37	138.86
Depreciation/Amortization	-	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-	-
Unusual Expense (Income)	-	-	-	-	-
Other Operating Expenses, Total	-	-	-	-	-
Total Operating Expense	286.61	268.93	225.32	216.92	209.59
Operating Income	153.05	145.67	202.36	87.48	22.20
Interest Income(Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Other, Net	-	-	-	-	-
Income Before Tax	141.83	134.56	191.47	76.74	11.65
Income After Tax	98.87	470.41	191.47	76.74	11.65
Minority Interest	-	-	-	-	-
Equity In Affiliates	-	-	-	-	-
Net Income Before Extra. Items	98.87	470.41	191.47	76.74	11.65
Accounting Change	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Extraordinary Item	-	-	-	-	-
Net Income	98.87	470.41	191.47	76.74	11.65
Preferred Dividends	-	-	-	-	-
Income Available to Common Excl. Extra Items	98.87	470.41	191.47	76.74	11.65
Income Available to Common Incl. Extra Items	98.87	470.41	191.47	76.74	11.65
Basic Weighted Average Shares	-	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-	-
Dilution Adjustment	0.00	21.75	7.37	0.00	0.00
Diluted Weighted Average Shares	109.37	120.63	115.83	110.17	107.73
Diluted EPS Excluding Extraordinary Items	0.90	4.08	1.72	0.70	0.11
Diluted EPS Including Extraordinary Items	-	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-	-
Depreciation, Supplemental	-	-	-	-	-
Total Special Items	-	-	-	-	-
Normalized Income Before Taxes	-	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-	-
Normalized Income After Taxes	-	-	-	-	-
Normalized Income Avail to Common	-	-	-	-	-
Basic Normalized EPS	-	-	-	-	-
Diluted Normalized EPS	0.90	4.08	1.72	0.70	0.11

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Revenue	1,378.48	445.82	459.07	379.27
Other Revenue, Total	-	-	-	-
Total Revenue	1,378.48	445.82	459.07	379.27
Cost of Revenue, Total	84.45	4.22	2.09	1.69
Gross Profit	1,294.02	441.61	456.98	377.58
Selling/General/Admin. Expenses, Total	210.75	117.26	65.20	52.92
Research & Development	625.55	529.51	489.25	398.76
Depreciation/Amortization	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	-	-	-	0.10
Other Operating Expenses, Total	-	-	-	-
Total Operating Expense	920.76	650.98	556.55	453.47
Operating Income	457.71	-205.16	-97.47	-74.20
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	-	-	-	-
Income Before Tax	414.42	-222.89	-104.47	-71.95
Income After Tax	750.27	-221.76	-104.47	-67.83
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	750.27	-221.76	-104.47	-67.83
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	750.27	-221.76	-104.47	-67.83
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	750.27	-221.76	-104.47	-67.83
Income Available to Common Incl. Extra Items	750.27	-221.76	-104.47	-67.83
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	29.13	0.00	0.00	0.00
Diluted Weighted Average Shares	115.38	90.61	82.93	79.78
Diluted EPS Excluding Extraordinary Items	6.75	-2.45	-1.26	-0.85
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	6.75	-2.45	-1.26	-0.85

In Millions of USD (except for per share items)	As of 2013-03-31	As of 2012-12-31	As of 2012-09-30	As of 2012-06-30	As of 2012-03-31
Cash & Equivalents	180.36	230.28	119.00	171.94	394.58
Short Term Investments	127.35	77.82	143.55	129.08	37.71
Cash and Short Term Investments	307.71	308.10	262.55	301.02	432.30
Accounts Receivable - Trade, Net	802.64	693.12	601.27	435.38	238.35
Receivables - Other	-	-	-	-	-
Total Receivables, Net	802.64	693.12	601.27	435.38	238.35
Total Inventory	37.77	22.09	29.57	24.43	26.82
Prepaid Expenses	53.16	28.02	55.21	8.37	-0.55
Other Current Assets, Total	105.84	154.68	-	-	-
Total Current Assets	1,307.12	1,206.01	948.60	769.19	696.91
Property/Plant/Equipment, Total - Gross	-	-	-	-	-
Accumulated Depreciation, Total	-	-	-	-	-
Goodwill, Net	-	-	-	-	-
Intangibles, Net	-	-	-	-	-
Long Term Investments	346.61	271.23	312.60	288.32	254.74
Other Long Term Assets, Total	229.89	223.31	26.50	27.71	28.55
Total Assets	2,276.00	2,080.49	1,660.62	1,457.50	1,350.16
Accounts Payable	24.73	38.93	21.94	25.67	25.39
Accrued Expenses	120.68	72.41	102.28	101.10	81.33
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	1.47	1.37	1.28	1.18	1.09
Other Current liabilities, Total	50.36	50.83	53.07	55.27	52.57
Total Current Liabilities	197.24	163.55	178.57	183.22	160.39
Long Term Debt	302.27	296.52	290.96	285.49	280.21
Capital Lease Obligations	159.01	159.44	159.50	159.56	159.53
Total Long Term Debt	461.27	455.95	450.46	445.05	439.74
Total Debt	462.75	457.33	451.74	446.23	440.83
Deferred Income Tax	-	-	-	-	-
Minority Interest	-	-	-	-	-
Other Liabilities, Total	211.13	215.60	225.56	234.57	246.01
Total Liabilities	869.65	835.11	854.59	862.84	846.13
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	0.10	0.10	0.10	0.10	0.10
Additional Paid-In Capital	1,826.08	1,763.51	1,795.29	1,775.86	1,760.94
Retained Earnings (Accumulated Deficit)	-418.18	-517.05	-987.46	-1,178.93	-1,255.67
Treasury Stock - Common	-	-	-	-	-
Other Equity, Total	-1.64	-1.17	-1.90	-2.37	-1.34
Total Equity	1,406.35	1,245.38	806.02	594.66	504.02
Total Liabilities & Shareholders' Equity	2,276.00	2,080.49	1,660.62	1,457.50	1,350.16
Shares Outs - Common Stock Primary Issue	-	-	-	-	-
Total Common Shares Outstanding	97.71	97.29	96.50	96.03	95.06

In Millions of USD (except for per share items)	As of 2012-12-31	As of 2011-12-31	As of 2010-12-31	As of 2009-12-31
Cash & Equivalents	230.28	483.61	112.57	207.07
Short Term Investments	77.82	43.33	136.80	134.25
Cash and Short Term Investments	308.10	526.94	249.37	341.33
Accounts Receivable - Trade, Net	693.12	103.03	81.92	62.70
Receivables - Other	-	-	-	-
Total Receivables, Net	693.12	103.03	81.92	65.57
Total Inventory	22.09	14.65	1.42	-
Prepaid Expenses	28.02	19.19	24.91	18.61
Other Current Assets, Total	154.68	1.96	-	-
Total Current Assets	1,206.01	665.78	357.62	425.51
Property/Plant/Equipment, Total - Gross	560.45	526.09	478.76	372.45
Accumulated Depreciation, Total	-180.51	-158.14	-131.31	-112.78
Goodwill, Net	-	-	-	-
Intangibles, Net	-	-	-	-
Long Term Investments	271.23	275.89	370.05	47.08
Other Long Term Assets, Total	223.31	13.96	14.31	8.94
Total Assets	2,080.49	1,323.58	1,089.43	741.20
Accounts Payable	38.93	27.74	23.21	19.82
Accrued Expenses	72.41	67.89	30.45	29.21
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	1.37	1.01	0.68	0.00
Other Current liabilities, Total	50.83	51.64	54.72	44.54
Total Current Liabilities	163.55	148.27	109.06	93.58
Long Term Debt	296.52	275.02	0.00	-
Capital Lease Obligations	159.44	159.51	159.35	109.02
Total Long Term Debt	455.95	434.53	159.35	109.02
Total Debt	457.33	435.53	160.03	109.02
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	215.60	255.05	293.21	141.84
Total Liabilities	835.11	837.85	561.62	344.44
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	0.10	0.09	0.09	0.08
Additional Paid-In Capital	1,763.51	1,754.82	1,575.78	1,336.73
Retained Earnings (Accumulated Deficit)	-517.05	-1,267.32	-1,045.56	-941.10
Treasury Stock - Common	-	-	-	-
Other Equity, Total	-1.17	-1.86	-2.49	1.04
Total Equity	1,245.38	485.73	527.82	396.76
Total Liabilities & Shareholders' Equity	2,080.49	1,323.58	1,089.43	741.20
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	97.29	92.80	89.42	81.11

In Millions of USD (except for per share items)	3 months ending 2013-03-31	12 months ending 2012-12-31	9 months ending 2012-09-30	6 months ending 2012-06-30	3 months ending 2012-03-31
Net Income/Starting Line	98.87	750.27	279.86	88.39	11.65
Depreciation/Depletion	9.41	36.94	27.16	17.83	8.42
Amortization	-	-	-	-	-
Deferred Taxes	39.52	-340.16	-	-	-
Non-Cash Items	65.98	151.13	84.68	56.22	31.28
Changes in Working Capital	-127.54	-672.80	-559.50	-327.87	-138.39
Cash from Operating Activities	86.25	-74.61	-167.80	-165.42	-87.04
Capital Expenditures	-21.20	-49.34	-34.17	-23.93	-11.05
Other Investing Cash Flow Items, Total	-126.48	-31.74	-138.00	-99.50	26.82
Cash from Investing Activities	-147.69	-81.07	-172.18	-123.42	15.77
Financing Cash Flow Items	-0.79	-158.99	-71.47	-61.44	-49.08
Total Cash Dividends Paid	-	-	-	-	-
Issuance (Retirement) of Stock, Net	12.96	63.55	48.44	39.63	31.83
Issuance (Retirement) of Debt, Net	-0.65	-2.20	-1.60	-1.01	-0.50
Cash from Financing Activities	11.52	-97.65	-24.64	-22.83	-17.75
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-49.91	-253.33	-364.61	-311.67	-89.03
Cash Interest Paid, Supplemental	-	21.95	-	-	-
Cash Taxes Paid, Supplemental	-	-	-	-	-

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Net Income/Starting Line	750.27	-221.76	-104.47	-67.83
Depreciation/Depletion	36.94	31.08	19.69	14.25
Amortization	-	-	-	-
Deferred Taxes	-340.16	-	-	-
Non-Cash Items	151.13	67.42	43.98	33.50
Changes in Working Capital	-672.80	-18.42	140.03	-49.85
Cash from Operating Activities	-74.61	-141.68	99.22	-69.94
Capital Expenditures	-49.34	-57.22	-99.69	-97.32
Other Investing Cash Flow Items, Total	-31.74	185.69	-337.34	95.17
Cash from Investing Activities	-81.07	128.47	-437.03	-2.15
Financing Cash Flow Items	-158.99	-142.58	-3.80	0.00
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	63.55	137.39	200.59	8.60
Issuance (Retirement) of Debt, Net	-2.20	389.44	46.52	22.77
Cash from Financing Activities	-97.65	384.25	243.31	31.36
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	-253.33	371.04	-94.50	-40.72
Cash Interest Paid, Supplemental	21.95	14.72	12.74	2.52
Cash Taxes Paid, Supplemental	-	-	-	-